möglich sobald bei der ZB eingereicht worden ist.
Biochim. Biophys. Acta-Rev. Cancer 1856, 130-143 (2015)
Radiation therapy is one of the most commonly used non-surgical intervention in tumor treatment and is often combined with other modalities to enhance its efficacy. Despite recent advances in radiation oncology, treatment responses, however, vary considerably between individual patients. A variety of approaches have been developed to enhance radiation response or to counteract resistance to ionizing radiation. Among them, a relatively novel class of radiation sensitizers comprises nanoparticles (NPs) which are highly efficient and selective systems in the nanometer range. NPs can either encapsulate radiation sensitizing agents, thereby protecting them from degradation, or sensitize cancer cells to ionizing radiation via their physicochemical properties, e.g. high Z number. Moreover, they can be chemically modified for active molecular targeting and the imaging of tumors. In this review we will focus on recent developments in nanotechnology, different classes and modifications of NPs and their radiation sensitizing properties.
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Schlagwörter Cancer Therapy ; Molecular Tumor Targeting ; Nanoparticles ; Nanotechnology ; Radiation Sensitization ; Radiation Therapy; Serum-albumin Nanoparticles; Iron-oxide Nanoparticles; Breast-cancer Cells; Phase-ii Trial; Plasmid-loaded Nanoparticles; Pep-pcl Nanoparticles; Gold Nanoparticles; In-vivo; Drug-delivery; Polymeric Nanoparticles
ISSN (print) / ISBN 1879-2561
Quellenangaben Band: 1856, Heft: 1, Seiten: 130-143
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Radiation Medicine (IRM)